(Last updated: December 16, 2021)

Appendix B: Panel Roster and Financial Disclosures

Invasive Mycoses

Invasive Mycoses (Cryptococcosis, Histoplasmosis, Coccidioidomycosis)
Member Institution Financial Disclosure
Company Relationship
Neil Ampel University of Arizona, College of Medicine None N/A
David Boulware University of Minnesota Medical School

Appili Therapeutics

Matinas BioPharma

 Research Support (paid to institution)
Richard Hamill Baylor College of Medicine None N/A
Carol Kauffman* University of Michigan Medical School and Veterans Affairs Ann Arbor Healthcare System

Cidara

Laboratoires SMB S.A.

 Data Safety Monitoring Board
Marisa Miceli University of Michigan Medical School

SCYNEXIS

F2G

Mayne

 Research Support (paid to institution)
SCYNEXIS Data Safety Monitoring Board
Astellas Consulting
Peter Pappas The University of Alabama at Birmingham, School of Medicine

Astellas Pharma

Merck

 Research Support (paid to institution)
Cidara Therapeutics Scientific Advisory Board
SCYNEXIS Advisory Board (Research Support)
John Perfect Duke University, School of Medicine Pfizer Scientific Advisory Board
* Group lead

Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim.

 

Download Guidelines

Related Content